• Fish Oils decrease the risk of developing fatal ventricular arrhythmias when there is a lack of blood flow to the heart

    Jul 03, 2008
         Scientists at the Department of Medicine, Stavanger University Hospital, Stavanger, Norway and the Institute of Medicine, University of Bergen, Bergen, Norway state Fish Oils save lives. They note that animal studies demonstrate evidence of an anti-arrhythmic effect of marine n-3 fatty acids (FAs). In humans the same mechanism may explain the observed reduction in sudden cardiac death (SCD) associated with intake of fish.
  • Harvard Researchers; Fish Oils reduce the risk of developing fatal ventricular arrhythmias, fatal coronary heart disease, and sudden cardiac death

    Jul 02, 2008
         Researchers from the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, and the Department of Epidemiology and Nutrition, Harvard School of Public Health feel strongly about fish oils. Large observational studies, randomized clinical trials, and experimental studies have evaluated the effects of fish and n-3 fatty acid consumption on fatal coronary heart disease (CHD) and sudden cardiac death (SCD), clinically defined events that most often share the final common pathway of fatal ventricular arrhythmia. These different study designs provide strong concordant evidence that modest consumption of fish or fish oil (1-2 servings per week of oily fish, or approximately 250 mg/day of EPA+DHA) substantially reduces the risk of CHD death and SCD.
  • Grape Seed extract reduces cognitive decline in animal model of Alzheimer's disease

    Jul 01, 2008
         Researchers at Mount Sinai School of Medicine in New York have discovered that administering Grape Seed Polyphenols reduces amyloid beta aggregation in the brain and slows cognitive impairment in a mouse model of Alzheimer's disease. Accumulation of amyloid beta compounds in the brains of Alzheimer's disease patients leads to the formation of plaques that are believed to be responsible for the memory loss and dementia that occurs with the disease.      For the current study, Giulio Pasinetti, MD, PhD, of Mount Sinai's Departments of Psychiatry and Neuroscience, and his associates used mice that were genetically modified to dependably develop Alzheimer's disease.